FGD5 and familial pancreatic carcinoma: Notably, excluding functioning as a ceRNA, lncRNA FGD5-AS1 may exert its biological effect via functioning as a transcription regulator or protein-binding RNA, and whether FGD5-AS1 could regulate the progression of pancreatic cancer via these mechanisms requires further investigation in subsequent studies.